NCT02654626View on ClinicalTrials.gov

A Multiple Ascending Dose Study of KBP-7072 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

16

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions

Healthy

Interventions

DRUG

KBP-7072

Drug Intervention

OTHER

Placebo

Trial Locations (1)

07094

Frontage Laboratories, Inc., Secaucus

Sponsors

Lead Sponsor

KBP Biosciences

All Listed Sponsors

lead

KBP Biosciences

INDUSTRY

NCT02654626 - A Multiple Ascending Dose Study of KBP-7072 in Healthy Subjects | Biotech Hunter | Biotech Hunter